An article released yesterday on the Merck Anti-PD1 clinical trial results can be found HERE.
I am on the Merck drug, currently receiving the low dose. Last time I was in for treatment they also informed they are adding several seats to this trial including changing the dosing schedule (right now I get it every 3 weeks but they are adding a schedule for every 2 weeks also!).
As I posted in my one of my previous entries:
"This study is showing the highest rate of durable melanoma responses of any drug we have tested thus far in this cancer, and it is doing it without serious side effects in the great majority of patients," Ribas said.
This is pretty amazing stuff. I know that folks will think that 38% isn't that great, but when traditional treatments were seeing just 15-20% responses with long term remission around 5% of patients - this is a HUGE step forward!